What question did this study set out to answer?

To evaluate the safety and hemodynamic effects of dexmedetomidine-fentanyl sedation during Transcatheter Aortic Valve Implantation (TAVI).

February 25, 2026Open Access

Hemodynamic Safety of Dexmedetomidine-Fentanyl Sedation During TAVI

Key Points

To evaluate the safety and hemodynamic effects of dexmedetomidine-fentanyl sedation during Transcatheter Aortic Valve Implantation (TAVI).
Used dexmedetomidine and fentanyl for sedation during TAVI procedures.
Monitored hemodynamic parameters throughout the procedure.
Assessed patient respiratory patterns and overall sedation effectiveness.
Maintained stable hemodynamic parameters during the procedure.
Patients exhibited spontaneous respiration.
Minimized perioperative risks compared to traditional sedation methods.

Abstract

Dexmedetomidine combined with fentanyl provides safe and effective sedation for TAVI, maintaining hemodynamic stability and spontaneous respiration. This sedation protocol minimizes perioperative risks and may improve procedural safety in high-risk patients.

Bookmark

View Full Paper

Bookmark

View Full Paper

Hemodynamic Safety of Dexmedetomidine-Fentanyl Sedation During TAVI

Key Points

Abstract

Cite This Study